ChemicalBook > CAS DataBase List > Tozasertib

Tozasertib

Product Name
Tozasertib
CAS No.
639089-54-6
Chemical Name
Tozasertib
Synonyms
VE465;VX 680;VE 465;CS-176;VE-465;VX-860;MK 0457;Tozasertib;L-001281814;VX-680/MK-0457
CBNumber
CB51513746
Molecular Formula
C23H28N8OS
Formula Weight
464.59
MOL File
639089-54-6.mol
More
Less

Tozasertib Property

Melting point:
248-253°C (dec.)
Density 
1.40±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
Soluble in DMSO (up to 100 mg/ml).
form 
powder
pka
14.09±0.70(Predicted)
color 
white to beige
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

Precautionary statements

P280Wear protective gloves/protective clothing/eye protection/face protection.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML2158
Product name
VX-680
Purity
≥98% (HPLC)
Packaging
10mg
Price
$73.8
Updated
2025/07/31
Cayman Chemical
Product number
13600
Product name
MK-0457
Purity
≥98%
Packaging
25mg
Price
$86
Updated
2024/03/01
Cayman Chemical
Product number
13600
Product name
MK-0457
Purity
≥98%
Packaging
50mg
Price
$161
Updated
2024/03/01
Cayman Chemical
Product number
13600
Product name
MK-0457
Purity
≥98%
Packaging
100mg
Price
$302
Updated
2024/03/01
Cayman Chemical
Product number
13600
Product name
MK-0457
Purity
≥98%
Packaging
250mg
Price
$546
Updated
2024/03/01
More
Less

Tozasertib Chemical Properties,Usage,Production

Description

The Aurora kinases (A, B, and C) are a family of serine-threonine kinases that regulate various stages of mitotic function. With significant roles in cell cycle and cell division, Aurora kinase gene amplification and overexpression are linked to tumorigenesis. MK-0457 is a potent pan-Aurora kinase inhibitor but favors Aurora A (Ki = 0.6 nM) over Aurora B (Ki = 18 nM) or Aurora C (Ki = 4.6 nM). It shows selectivity against a panel of more than 190 different protein kinases. MK-0457 effectively inhibits proliferation of several different cell lines of clear cell renal carcinoma (IC50s = <10 μM) and blocks the growth of tumors in a rodent model of cancer (80 mg/kg), inhibiting histone H3 phosphorylation and increasing apoptosis. By depleting Aurora activity, MK-0457 disrupts bipolar spindle formation during mitosis, arresting cell cycle progression at the G2/M phase.

Chemical Properties

White Solid

Uses

Tozasertib is used as a multikinase inhibitor once used for cancer treatment.

Definition

ChEBI: N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide is a N-arylpiperazine.

Biochem/physiol Actions

VX-680 is an ATP site-targeting potent aurora kinase inhibitor (Aurara A/B/C Ki(app) = 0.6/18/4.6 nM) that affects FLT3, BCR-Abl, BCR-Abl (T315I), Lck, ITK, Src, and Fyn only at higher concentrations (Ki(app) = 30, 30, 42, 80, 220, 350, 520 nM, respectively) and exhibits little inhibitory potency toward 52 other kinases (Ki(app) >1 μM). VX-680 exhibits potent antiproliferation activity in a wide variety of cancer cultures (IC50 from 15 to 113 nM) as a result of cell cycle arrest and apoptosis induction, as well as causes tumor retardation (by 98% on day 13; 75 mg/kg b.i.d i.p.; HL-60 in mice) and regression (2 mg/kg/h 3 d/wk i.v. infusion; HCT116 in rats) in vivo. Crystallography data reveal a tight association of VX-680 with a hydrophobic pocket present only in a closed, inactive kinase conformation, which forms the basis of its selectivity profile, including its activity toward wild-type and the Imatinib-resistant (T315I) Abl.

Synthesis

109-01-3

639090-55-4

639089-54-6

General synthesis of N-(4-((4-((4-((5-methyl-1H-pyrazol-3-yl)amino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)sulfanyl)phenyl)aminocyclopropanecarboxylic acid) and N-[4-[[4-chloro-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-yl]sulfanyl]phenyl]aminocyclopropane carboxylic acid as the raw materials The procedure was as follows: N-methylpiperazine (10 mL) was added to compound D (2.373 g, 5.92 mmol) and the reaction mixture was stirred at 110°C for 2 hours. Upon completion of the reaction, the excess N-methylpiperazine was removed by distillation under reduced pressure. The residue was dissolved in ethyl acetate, washed sequentially with aqueous sodium bicarbonate and dried over magnesium sulfate, and subsequently concentrated. The resulting residue was purified by methanol crystallization to afford colorless crystals of target product I (1.82 g, 66% yield). The product was characterized by 1H-NMR (DMSO-d6) with chemical shifts δ of 0.81 (4H, d), 1.79 (1H, m), 2.01 (3H, s), 2.18 (3H, s), 2.30 (4H, m), 3.35 (masked signal), 5.42 (1H, s), 6.02 (1H, br s), 7.47 (2H, d), and 7.69 (2H, d), 9.22 (1H, s), 10.39 (1H, s), 11.69 (1H, s).

References

[1] ELIZABETH A HARRINGTON. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo[J]. Nature Medicine, 2004, 10 3: 262-267. DOI:10.1038/nm1003
[2] FEI FEI. Activity of the Aurora kinase inhibitor VX-680 against Bcr/Abl-positive acute lymphoblastic leukemias.[J]. Molecular Cancer Therapeutics, 2010: 1318-1327. DOI:10.1158/1535-7163.mct-10-0069
[3] ALEXANDER DEWERTH. In vitro evaluation of the Aurora kinase inhibitor VX-680 for Hepatoblastoma.[J]. Pediatric Surgery International, 2012: 579-589. DOI:10.1007/s00383-012-3086-6

Tozasertib Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Tozasertib Suppliers

Canada 1 China 196 Germany 1 India 2 The Netherlands 1 United Kingdom 4 United States 29 Global 234
Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
96815
Advantage
76
Yangzhou Siyu Chemical Co.,Ltd.
Tel
0514-87325867
Fax
0086-514-87325867
Email
sales@siyuchem.com
Country
China
ProdList
370
Advantage
55
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6003
Advantage
61
JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Fax
86-021-50426522,50426273
Email
sales@jingyan-chemical.com
Country
China
ProdList
9976
Advantage
60
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 18971495150;
Email
sales@sun-shinechem.com
Country
China
ProdList
1077
Advantage
64
VDM Biochemicals
Tel
0330-2528181
Fax
0330-2528171
Email
sales@vdmbio.com
Country
United States
ProdList
510
Advantage
64
Shanghai Paulshine Chemical Co., Ltd.
Tel
+86-021-37788663
Fax
+86-021-37788663
Country
China
ProdList
186
Advantage
64
Shanghai Longsheng chemical Co.,Ltd.
Tel
021-58099652-8005 13585536065
Fax
021-58099609
Email
bin.wu@shlschem.com
Country
China
ProdList
9883
Advantage
59
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
15883
Advantage
64
More
Less

View Lastest Price from Tozasertib manufacturers

Career Henan Chemical Co
Product
Tozasertib 639089-54-6
Price
US $1.00/g
Min. Order
100g
Purity
99%
Supply Ability
G/KG/T
Release date
2019-12-20

639089-54-6, TozasertibRelated Search:

Tegaserod Levodropropizine Kresoxim-methyl Piperazine METSULFURON METHYL Methyl acrylate Methyl cellulose Methanol N-Aminoethylpiperazine Bensulfuron methyl Piperacillin 2-Ethylhexyl ferulate Methylparaben Pyrazole Trametinib Elexacaftor Methyl VX 702

  • Cyclopropane carboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino) -pyrimidin-2ylsulphanyl]-phenyl}-amide
  • VX-680/MK-0457
  • N-(4-(4-(5-methyl-1H-pyrazol-3-ylamino)-6-(1-methylpiperidin-4-ylamino)pyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide
  • MK 0457
  • N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide
  • Tozasertib
  • VX 680
  • Cyclopropanecarboxamide, N-(4-((4-(4-methyl-1-piperazinyl)-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)thio)phenyl)-
  • VX680;MK0457;VX 680 (MK 0457;TOZASERTIB)
  • CS-176
  • VE 465
  • VE465
  • VE-465
  • VX680; VX 680; VX-680; MK0457; MK 0457; MK-0457; VE465; VE-465; VE 465; TOZASERTIB
  • TOZASERTIB;MK-0457;MK0457;VX680;VX 680;MK 0457
  • N-(4-(4-(5-Methyl-1H-pyrazol-3-ylamino)-6-(1-methylpiperidin-4-ylamino)pyrimidin-2-ylthio)phen
  • N-(4-(4-(5-methyl-1H-pyrazol-3-ylamino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide
  • Tozasertib N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide
  • VX-680(Tozasertib)
  • Tozasertib(MK-0457,VX-680)
  • VX-860
  • N-[4-({4-[(3-METHYL-1H-PYRAZOL-5-YL)AMINO]-6-(4-METHYLPIPERAZIN-1-YL)PYRIMIDIN-2-YL}SULFANYL)PHENYL]CYCLOPROPANECARBOXAMIDE
  • tozasertib (MK-0457)
  • MK-0457,Tozasertib
  • Cyclopropanecarboxylic acid N-(4-((4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-yl)sulfanyl)phenyl)amide
  • L-001281814
  • Tozasertib/VX-680
  • N-(4-(4-(3-methyl-1H-pyrazol-5-ylamino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide
  • VX-680 (MK-0457)(Tozasertib)
  • Tozasertib￡VX680￡MK0457
  • Tozasertib Free Base
  • N-[4-[[4-(4-Methylpiperazin-1-yl)-6-[(5-Methyl-1H-pyrazol-3-yl)aMino]pyriMidin-2-yl]thio]phenyl]cyclopropanecarboxaMide
  • VX-680 (Tozasertib, MK-0457)
  • Tozasertib USP/EP/BP
  • N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide
  • MK-0457 Tozasertib VX-680
  • VX-680 (MK-0457), Aurora kinase inhibitor
  • Tozasertib, 10 mM in DMSO
  • N-[4-({4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide
  • Tozasertib（639089-54-6）
  • 639089-54-6
  • C24H30N8OS
  • C23H28N8OS
  • Inhibitors
  • A multikinase inhibitor.
  • Inhibitor
  • Aromatics
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Mutagenesis Research Chemicals
  • Pharmaceuticals